According to a new study, an investigational blood test can reliably and efficiently identify colon cancer in middle-aged ...
Oxford BioDynamics, Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, announces the publication of compelling ...